Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:collaboratesWith |
gptkb:Eisai_Co.,_Ltd.
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:focus |
neurodegenerative diseases
|
| gptkbp:formerName |
BioArctic AB
|
| gptkbp:foundedYear |
2003
|
| gptkbp:founder |
Pär Gellerfors
|
| gptkbp:headquartersLocation |
gptkb:Stockholm,_Sweden
|
| https://www.w3.org/2000/01/rdf-schema#label |
Autograph ABP
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
gptkb:lecanemab
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:Nasdaq_Stockholm
|
| gptkbp:website |
https://www.autographabp.com/
|
| gptkbp:bfsParent |
gptkb:Iniva
gptkb:Rivington_Place |
| gptkbp:bfsLayer |
7
|